A snapshot on current approaches to lymphadenectomy in liver resection for intrahepatic cholangiocarcinoma: results from an international survey.
Intrahepatic Cholangiocarcinoma
Liver resection
Lymphadenectomy
Survey
Journal
Updates in surgery
ISSN: 2038-3312
Titre abrégé: Updates Surg
Pays: Italy
ID NLM: 101539818
Informations de publication
Date de publication:
07 May 2024
07 May 2024
Historique:
received:
02
01
2024
accepted:
10
04
2024
medline:
7
5
2024
pubmed:
7
5
2024
entrez:
7
5
2024
Statut:
aheadofprint
Résumé
The use of lymphadenectomy (LND) during resection of intrahepatic cholangiocarcinoma (ICC) is still debated, leading to differing practices in different centers and countries. The aim of this study was to assess such differences. A survey on LND for ICC was distributed to the members of the International Hepato-PancreatoBiliary Association (IHPBA) and the Italian Chapter of IHPBA (AICEP). Two-hundred thirty-four surgeons completed the survey (88% males; median age 46 years). Preoperative nodal staging was deemed mandatory/very important by 65%. Adequate LND was defined as hepatoduodenal ligament LND by 33%, LND at specific nodal stations by 28% and retrieval of > 5 nodes by 28%. The decision to perform LND was influenced by comorbidities (48%), chronic liver disease (38%) and satellitosis (32%). Most participants modify perioperative management in case of clinically positive nodes, 50% stating they would give neoadjuvant therapy. The role of LND in clinically node negative disease was adequate staging for 88%, survival benefit for 50.5% and clinical trials eligibility for 18.5%. Our survey confirms heterogeneity in the evaluation of role and extent of LND for ICC, how this relates to subjective perception of importance of LND, and need of a systematic approach in this area.
Identifiants
pubmed: 38713394
doi: 10.1007/s13304-024-01852-0
pii: 10.1007/s13304-024-01852-0
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
de Jong MC, Nathan H, Sotiropoulos GC et al (2011) Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 29:3140–3145. https://doi.org/10.1200/JCO.2011.35.6519
doi: 10.1200/JCO.2011.35.6519
pubmed: 21730269
Mavros MN, Economopoulos KP, Alexiou VG, Pawlik TM (2014) Treatment and prognosis for patients with intrahepatic cholangiocarcinoma: systematic review and meta-analysis. JAMA Surg 149:565–574. https://doi.org/10.1001/jamasurg.2013.5137
doi: 10.1001/jamasurg.2013.5137
pubmed: 24718873
Aliseda D, Sapisochin G, Martí-Cruchaga P et al (2023) Association of laparoscopic surgery with improved perioperative and survival outcomes in patients with resectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis from propensity-score matched studies. Ann Surg Oncol 30:4888–4901. https://doi.org/10.1245/s10434-023-13498-0
doi: 10.1245/s10434-023-13498-0
pubmed: 37115372
pmcid: 10319676
Lamarca A, Edeline J, McNamara MG et al (2020) Current standards and future perspectives in adjuvant treatment for biliary tract cancers. Cancer Treat Rev 84:101936. https://doi.org/10.1016/j.ctrv.2019.101936
doi: 10.1016/j.ctrv.2019.101936
pubmed: 31986437
Akateh C, Ejaz AM, Pawlik TM, Cloyd JM (2020) Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma. World J Hepatol 12:693–708. https://doi.org/10.4254/wjh.v12.i10.693
doi: 10.4254/wjh.v12.i10.693
pubmed: 33200010
pmcid: 7643214
Sulpice L, Rayar M, Boucher E et al (2012) Treatment of recurrent intrahepatic cholangiocarcinoma. Br J Surg 99:1711–1717. https://doi.org/10.1002/bjs.8953
doi: 10.1002/bjs.8953
pubmed: 23132419
Park HM, Yun SP, Lee EC et al (2016) Outcomes for patients with recurrent intrahepatic cholangiocarcinoma after surgery. Ann Surg Oncol 23:4392–4400. https://doi.org/10.1245/s10434-016-5454-2
doi: 10.1245/s10434-016-5454-2
pubmed: 27581609
Navarro JG, Lee JH, Kang I et al (2020) Prognostic significance of and risk prediction model for lymph node metastasis in resectable intrahepatic cholangiocarcinoma: do all require lymph node dissection? HPB 22:1411–1419. https://doi.org/10.1016/j.hpb.2020.01.009
doi: 10.1016/j.hpb.2020.01.009
pubmed: 32046923
Tsilimigras DI, Sahara K, Paredes AZ et al (2021) Predicting lymph node metastasis in intrahepatic cholangiocarcinoma. J Gastrointest Surg 25:1156–1163. https://doi.org/10.1007/s11605-020-04720-5
doi: 10.1007/s11605-020-04720-5
pubmed: 32757124
Sposito C, Ratti F, Cucchetti A et al (2023) Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node-negative intrahepatic cholangiocarcinoma. J Hepatol 78:356–363. https://doi.org/10.1016/j.jhep.2022.10.021
doi: 10.1016/j.jhep.2022.10.021
pubmed: 36328332
Vogel A, Bridgewater J, Edeline J et al (2023) Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
doi: 10.1016/j.annonc.2022.10.506
pubmed: 36372281
Chun YS, Pawlik TM, Vauthey J-N (2018) 8th Edition of the AJCC cancer staging manual: pancreas and hepatobiliary cancers. Ann Surg Oncol 25:845–847
doi: 10.1245/s10434-017-6025-x
pubmed: 28752469
Yoh T, Cauchy F, Le Roy B et al (2019) Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: a multicenter study. Surgery 166:975–982. https://doi.org/10.1016/J.SURG.2019.06.025
doi: 10.1016/J.SURG.2019.06.025
pubmed: 31421869
Bagante F, Spolverato G, Weiss M et al (2018) Surgical management of intrahepatic cholangiocarcinoma in patients with cirrhosis: impact of lymphadenectomy on peri-operative outcomes. World J Surg 42:2551–2560. https://doi.org/10.1007/s00268-017-4453-1
doi: 10.1007/s00268-017-4453-1
pubmed: 29299649
Zhou R, Lu D, Li W et al (2019) Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis. HPB 21:784–792. https://doi.org/10.1016/j.hpb.2018.12.011
doi: 10.1016/j.hpb.2018.12.011
pubmed: 30878490
Eysenbach G (2004) Improving the quality of Web surveys: the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). J Med Internet Res. https://doi.org/10.2196/JMIR.6.3.E34
doi: 10.2196/JMIR.6.3.E34
pubmed: 15471763
pmcid: 1550622
Harris PA, Taylor R, Thielke R et al (2009) Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377–381. https://doi.org/10.1016/j.jbi.2008.08.010
doi: 10.1016/j.jbi.2008.08.010
pubmed: 18929686
Jiang L, Tan H, Panje CM et al (2016) Role of 18F-FDG PET/CT imaging in intrahepatic cholangiocarcinoma. Clin Nucl Med 41:1–7. https://doi.org/10.1097/RLU.0000000000000998
doi: 10.1097/RLU.0000000000000998
pubmed: 26402131
Aljiffry M, Abdulelah A, Walsh M et al (2009) Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature. J Am Coll Surg 208:134–147. https://doi.org/10.1016/J.JAMCOLLSURG.2008.09.007
doi: 10.1016/J.JAMCOLLSURG.2008.09.007
pubmed: 19228515
Zhang XF, Xue F, Dong DH et al (2021) Number and station of lymph node metastasis after curative-intent resection of intrahepatic cholangiocarcinoma impact prognosis. Ann Surg 274:E1187–E1195. https://doi.org/10.1097/SLA.0000000000003788
doi: 10.1097/SLA.0000000000003788
pubmed: 31972643
Choi S-B, Kim K-S, Choi J-Y et al (2009) The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 16:3048–3056. https://doi.org/10.1245/S10434-009-0631-1
doi: 10.1245/S10434-009-0631-1
pubmed: 19626372
Shiraiwa DK, Carvalho PFDC, Maeda CT et al (2020) The role of minimally invasive hepatectomy for hilar and intrahepatic cholangiocarcinoma: a systematic review of the literature. J Surg Oncol 121:863–872. https://doi.org/10.1002/JSO.25821
doi: 10.1002/JSO.25821
pubmed: 31902142
Levi Sandri GB, Spoletini G, Mascianà G et al (2017) The role of minimally invasive surgery in the treatment of cholangiocarcinoma. Eur J Surg Oncol 43:1617–1621. https://doi.org/10.1016/J.EJSO.2017.02.012
doi: 10.1016/J.EJSO.2017.02.012
pubmed: 28292628
Patrone R, Izzo F, Palaia R et al (2021) Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: a systematic review. World J Gastrointest Oncol 13:2203–2215. https://doi.org/10.4251/WJGO.V13.I12.2203
doi: 10.4251/WJGO.V13.I12.2203
pubmed: 35070052
pmcid: 8713325
Hamad A, Ansari A, Li Y et al (2022) Short- and long-term outcomes following robotic and open resection for intrahepatic cholangiocarcinoma: a national cohort study. Surg Oncol. https://doi.org/10.1016/J.SURONC.2022.101790
doi: 10.1016/J.SURONC.2022.101790
pubmed: 35717859
Sposito C, Cucchetti A, Mazzaferro V (2023) Reply to: “Letter regarding ‘Survival benefit of adequate lymphadenectomy in patients undergoing liver resection for clinically node negative intrahepatic cholangiocarcinoma.’” J Hepatol 78:e170–e172. https://doi.org/10.1016/j.jhep.2023.01.020
doi: 10.1016/j.jhep.2023.01.020
pubmed: 36736594
Yonemura Y, Wu CC, Fukushima N et al (2008) Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol 13:132–137. https://doi.org/10.1007/S10147-007-0727-1
doi: 10.1007/S10147-007-0727-1
pubmed: 18463957
Kulig J, Popiela T, Kolodziejczyk P et al (2007) Standard D2 versus extended D2 (D2+) lymphadenectomy for gastric cancer: an interim safety analysis of a multicenter, randomized, clinical trial. Am J Surg 193:10–15. https://doi.org/10.1016/J.AMJSURG.2006.04.018
doi: 10.1016/J.AMJSURG.2006.04.018
pubmed: 17188080
Planellas P, Marinello F, Elorza G et al (2022) Extended versus standard complete mesocolon excision in sigmoid colon cancer: a multicenter randomized controlled trial. Ann Surg 275:271–280. https://doi.org/10.1097/SLA.0000000000005161
doi: 10.1097/SLA.0000000000005161
pubmed: 34417367
Primrose JN, Neoptolemos J, Palmer DH et al (2019) Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol 20:663–673. https://doi.org/10.1016/S1470-2045(18)30915-X
doi: 10.1016/S1470-2045(18)30915-X
pubmed: 30922733
Jansson H, Villard C, Nooijen LE et al (2023) Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. Eur J Surg Oncol 49:688–699. https://doi.org/10.1016/J.EJSO.2023.01.006
doi: 10.1016/J.EJSO.2023.01.006
pubmed: 36710214
Schmidt B, Yoon SS (2012) Varying lymphadenectomies for gastric adenocarcinoma in the East compared with the west: effect on outcomes. Am Soc Clin Oncol Educ Book. https://doi.org/10.14694/EDBOOK_AM.2012.32.28
doi: 10.14694/EDBOOK_AM.2012.32.28
pubmed: 24451743
Otero de Pablos J, Mayol J (2020) Controversies in the management of lateral pelvic lymph nodes in patients with advanced rectal cancer: east or west? Front Surg. https://doi.org/10.3389/FSURG.2019.00079
doi: 10.3389/FSURG.2019.00079
pubmed: 32775341
pmcid: 7387862
Zhang XF, Chakedis J, Bagante F et al (2018) Trends in use of lymphadenectomy in surgery with curative intent for intrahepatic cholangiocarcinoma. Br J Surg 105:857–866. https://doi.org/10.1002/BJS.10827
doi: 10.1002/BJS.10827
pubmed: 29656380
Kommalapati A, Tella SH, Goyal G et al (2019) Association between treatment facility volume, therapy types and overall survival in patients with intrahepatic cholangiocarcinoma. HPB (Oxford) 21:379–386. https://doi.org/10.1016/J.HPB.2018.08.004
doi: 10.1016/J.HPB.2018.08.004
pubmed: 30266490
Ratti F, Cipriani F, Ingallinella S et al (2023) Robotic approach for lymphadenectomy in biliary tumors: the missing ring between the benefits of laparoscopic and reproducibility of open approach? Ann Surg 278:E780–E788. https://doi.org/10.1097/SLA.0000000000005748
doi: 10.1097/SLA.0000000000005748
pubmed: 36341600